## Abstract A previous study of 18 primary or metastatic prostate cancers showed loss of genetic markers on chromosome 8; 10, or 16 in more than 50% of cases [Bergerheim USR et al. (1991) Genes Chromosom Cancer 3:215โ220]. The small size and infiltrative nature of primary prostatic tumors have hind
Loss of Chromosome 17 loci in prostate cancer detected by polymerase chain reaction quantitation of allelic markers
โ Scribed by Arthur R. Brothman; Michael R. Steele; Briana J. Williams; Emma Jones; Shannon Odelberg; Hans M. Albertsen; Lynn B. Jorde; L. Ralph Rohr; Robert A. Stephenson
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 619 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1045-2257
No coin nor oath required. For personal study only.
โฆ Synopsis
Using a polymerase chain reaction/microsatellite marker system, we demonstrated that 6 of 22 (27%) clinical stage B (early) primary prostate tumors showed loss of heterozygosity at one or more of five loci on chromosome 17. The sensitivity of this study was increased by use of a Phosphorlmager and statistical analysis of replicate tumor-normal DNA pairs. Two patients showed tumor-specific interstitial loss at a locus in close proximity to the familial breast cancer gene BRCAI. These findings suggest that genes on the proximal long arm of chromosome I7 play a pivotal role in the early development of at least a subset of prostatic tumors. Genes Chromosom Cancer 13:278-284 (1995). 0 1995 Wiley-Liss. Inc.
๐ SIMILAR VOLUMES
We employed the arbitrarily primed polymerase chain reaction (AP-PCR), which is a PCR-based genomic fingerprinting technique, to detect novel genetic alterations in human astrocytomas. DNA fingerprints generated by arbitrary primers were compared in normal lymphocytes and tumor tissues from the same